Apthous ulcer tretment

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image

Aphthous Ulcer (Recurrent Aphthous Stomatitis) — Treatment

Minor aphthous ulcers of the labial mucosa and ventral tongue showing yellow fibrinous base and erythematous periphery
Minor aphthous ulcers — labial mucosa and ventral tongue

Types (Classify First, Then Treat)

TypeSizeFeaturesDuration
Minor (85%)<10 mmAnterior oral cavity, heals without scarring7–10 days
Major (Sutton disease) (10%)>1 cmPosterior cavity/oropharynx, deeply cratered, very painfulUp to 6 weeks
Herpetiform<2 mm, multiplePinhead-sized, widespread, no vesicular phaseVariable

Treatment (Severity-Based)

Mild / Infrequent Minor Ulcers

  • Symptomatic management — requires little else
  • Chlorhexidine rinses — help maintain hygiene and reduce duration
  • OTC topical protectants and analgesics (e.g., benzocaine-containing preparations)
  • Compounded rinses containing combinations of topical steroids, antifungals, and local anesthetics (especially for odynophagia)

Moderate — When Treatment Is Necessary

  • Topical corticosteroids — the general mainstay of treatment (e.g., triamcinolone acetonide in orabase, fluocinonide gel)
  • Topical analgesics / anti-inflammatory agents — used in conjunction with steroids

Severe / Continuous Outbreaks / Major Aphthae

  • Systemic corticosteroids (short-term) — effective for severe or continuous outbreak series
  • Intralesional steroid injection — useful for larger (major) aphthae or lesions unresponsive to topical therapy

Refractory / Immunocompromised (HIV)

  • Thalidomide 200 mg/day — shown to be effective for treatment (note: not effective for prevention of recurrence)
  • Systemic immunosuppressives — second-line options include:
    • Azathioprine
    • Colchicine
    • Pentoxifylline
    • Dapsone
    • TNF-α antagonists

Special Considerations

  • In HIV/immunocompromised patients: ulcers are more severe, deeper, more painful; may coalesce; serve as a marker for HIV disease progression. Monitor body weight and provide liquid nutritional supplements.
  • Major aphthae: always biopsy the edge to rule out lymphoma or SCC before initiating treatment.
  • Tobacco use has a negative association with aphthous ulcers (i.e., smokers have lower rates — but this does NOT suggest tobacco as treatment).
  • Aphthous ulcers have no vesicular phase — this distinguishes them from herpes simplex lesions, which occur on keratinized mucosa.

Sources: Cummings Otolaryngology Head and Neck Surgery; Cummings Otolaryngology (HIV/immunocompromised section)
This is a shared conversation. Sign in to Orris to start your own chat.